Search Results - "Dworowy, Sebastian"
-
1
Effects of Transendocardial Delivery of Bone Marrow–Derived CD133+ Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina
Published in Circulation research (17-02-2017)“…Rationale:New therapies for refractory angina are needed.Objective:Assessment of transendocardial delivery of bone marrow CD133+ cells in patients with…”
Get full text
Journal Article -
2
Mobilization of CD34+CXCR4+ Stem/Progenitor Cells and the Parameters of Left Ventricular Function and Remodeling in 1-Year Follow-up of Patients with Acute Myocardial Infarction
Published in Mediators of Inflammation (01-01-2012)“…Mobilization of stem cells in acute MI might signify the reparatory response. Aim of the Study. Prospective evaluation of correlation between CD34+CXCR4+ cell…”
Get full text
Journal Article -
3
Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non‐treatable Cardiac diseasE (SCIENCE)
Published in European journal of heart failure (01-08-2019)“…Aims Ischaemic heart failure (IHF) patients have a poor prognosis even with current guideline‐derived therapy. Intramyocardial injections of autologous or…”
Get full text
Journal Article -
4
Effects of Transendocardial Delivery of Bone Marrow–Derived CD133+ Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina: Final Results of Randomized, Double-Blinded, Placebo-Controlled REGENT-VSEL Trial
Published in Circulation research (17-02-2017)“…RATIONALE:New therapies for refractory angina are needed. OBJECTIVE:Assessment of transendocardial delivery of bone marrow CD133 cells in patients with…”
Get full text
Journal Article -
5
Outcomes of biodegradable polymer sirolimus-eluting PROLIM stent in patients with coronary artery disease. Results of 12-month follow-up of prospective registry
Published in Kardiologia polska (01-01-2016)“…Data from clinical trials suggested that biodegradable-polymer-based drug-eluting stents (DES) might improve long-term clinical outcomes. PROLIM (Balton,…”
Get full text
Journal Article -
6
Drug eluting stent or drug eluting balloon? Which is the better device to treat instent restenosis?
Published in Postępy w kardiologii interwencyjnej (2011)Get full text
Journal Article -
7
Effects of Trans-Endocardial Delivery of Bone Marrow-Derived CD133+ Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina: Final Results of Randomized, Double-Blinded, Placebo-Controlled REGENT-VSEL Trial
Published in Circulation research (09-12-2016)“…RATIONALE:New therapies for refractory angina are needed. OBJECTIVE:Assessment of trans-endocardial delivery of bone marrow (BM) CD133+ cells in patients with…”
Get full text
Journal Article -
8
Abstract 19648: Effect of Transendocardial Delivery of Bone Marrow-Derived Cd133+ Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina: Final 12-Months Results of Randomized, Double-Blinded, Placebo-Controlled Regent-vsel Trial
Published in Circulation (New York, N.Y.) (11-11-2016)“…IntroductionRefractory angina impairs the quality of life so new therapies are needed.HypothesisTransendocardial delivery of autologous bone marrow…”
Get full text
Journal Article -
9
Drug eluting stent or drug eluting balloon? Which is the better device to treat instent restenosis?
Published in Postępy w kardiologii interwencyjnej (01-06-2011)Get full text
Journal Article